Correction: Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL.

Autor: Sergio I; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Varricchio C; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Patel SK; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Del Gaizo M; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Russo E; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Orlando A; Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Peruzzi G; Center for Life Nano-Neuro Science, IIT, Rome, Italy., Ferrandino F; A.O.R.N. dei colli Monaldi V., Napoli, Italy., Tsaouli G; Department of Medical-Surgical Science and Translational Medicine, Sapienza University of Rome, Rome, Italy., Coni S; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Peluso D; Ph.D School of Applied Medical-Surgical Sciences, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Besharat ZM; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Campolo F; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Venneri MA; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Del Bufalo D; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Lai S; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Indraccolo S; Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy.; Basic and Translational Oncology Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Minuzzo S; Department of Surgery Oncology and Gastroenterology, University of Padua, Padua, Italy., La Starza R; Hematology Section, Department of Medicine and Surgery, and S. Maria Della Misericordia Hospital Perugia, CREO, Perugia, Italy., Bernardini G; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Screpanti I; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Campese AF; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Felli MP; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. mariapia.felli@uniroma1.it.

Publikováno v: Oncogene [Oncogene] 2024 Aug; Vol. 43 (34), pp. 2611.

Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts.

Autor: Boso D; Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128, Padova, Italy., Tognon M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Curtarello M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Minuzzo S; Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, Padova, 35124, Italy., Piga I; Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, Padova, 35124, Italy., Brillo V; Department of Biology, University of Padova, Padova, Italy., Lazzarini E; Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128, Padova, Italy., Carlet J; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Marra L; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Trento C; Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, Padova, 35124, Italy., Rasola A; Department of Biomedical Sciences, University of Padova, Padova, Italy., Masgras I; Department of Biomedical Sciences, University of Padova, Padova, Italy.; Institute of Neuroscience, National Research Council, Padova, Italy., Caporali L; Department of Biomedical and Neuromotor Sciences - DIBINEM, University of Bologna, Bologna, Italy., Del Ben F; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO)-IRCCS, Aviano, Italy., Brisotto G; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO)-IRCCS, Aviano, Italy., Turetta M; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO)-IRCCS, Aviano, Italy., Pastorelli R; Laboratory of Mass Spectrometry, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Brunelli L; Laboratory of Mass Spectrometry, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Navaglia F; Laboratory Medicine, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy., Esposito G; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Grassi A; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Indraccolo S; Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, 35128, Padova, Italy. stefano.indraccolo@unipd.it.; Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, Padova, 35124, Italy. stefano.indraccolo@unipd.it.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Aug 07; Vol. 42 (1), pp. 196. Date of Electronic Publication: 2023 Aug 07.

Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.

Autor: Agnusdei, V¹, Minuzzo, S², Frasson, C³, Grassi, A¹, Axelrod, F⁴, Satyal, S⁴, Gurney, A⁴, Hoey, T⁴, Seganfreddo, E³, Basso, G³, Valtorta, S⁵, Moresco, R M⁵, Amadori, A⁶, Indraccolo, S¹

Publikováno v: Leukemia (08876924). Feb2014, Vol. 28 Issue 2, p278-288. 11p. 1 Chart, 6 Graphs.

Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.

Autor: Masiero, M.¹, Minuzzo, S.¹, Pusceddu, I.², Moserle, L.¹, Persano, L.¹, Agnusdei, V.¹, Tosello, V.³, Basso, G.⁴, Amadori, A.^1,2, Indraccolo, S.² stefano.indraccolo@unipd.it

Publikováno v: Leukemia (08876924). Apr2011, Vol. 25 Issue 4, p588-598. 11p. 1 Black and White Photograph, 6 Graphs.

A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia.

Autor: da Silva-Diz V; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Cao B; Department of Medicinal Chemistry, School of Pharmacy, Rutgers University, Piscataway, NJ., Lancho O; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Chiles E; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Alasadi A; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ., Aleksandrova M; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Luo S; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Singh A; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Center for Systems and Computational Biology, Rutgers University, New Brunswick, NJ., Tao H; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ., Augeri D; Department of Medicinal Chemistry, School of Pharmacy, Rutgers University, Piscataway, NJ., Minuzzo S; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Indraccolo S; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Basic and Translational Oncology Unit, Veneto Institute of Oncology-Scientific Institute for Research, Hospitalization and Healthcare (IOV-IRCCS), Padova, Italy., Khiabanian H; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Center for Systems and Computational Biology, Rutgers University, New Brunswick, NJ.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ; and., Su X; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ., Jin S; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ., Herranz D; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ.

Publikováno v: Blood [Blood] 2021 Oct 14; Vol. 138 (15), pp. 1317-1330.